Published in J Clin Invest on February 01, 1982
Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes (2009) 1.87
AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem (2010) 1.60
Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes (2013) 1.08
Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors. J Clin Invest (1985) 0.98
Targeted enzyme therapy of experimental glomerulonephritis in rats. J Clin Invest (1991) 0.87
Effect of enzymatically generated reactive oxygen metabolites on the cyclic nucleotide content in isolated rat glomeruli. J Clin Invest (1984) 0.87
Increased cathepsin D-like activity in cortex, tubules, and glomeruli isolated from rats with experimental nephrotic syndrome. Biochem J (1984) 0.85
Effects of experimental nephrosis on basement-membrane components and enzymes of collagen biosynthesis in rat kidney. Biochem J (1985) 0.84
Renal neuraminidase. Characterization in normal rat kidney and measurement in experimentally induced nephrotic syndrome. Biochem J (1986) 0.77
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats. J Exp Med (1961) 4.85
Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab Invest (1970) 3.82
Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine. Clin Chim Acta (1972) 2.92
Molecular basis of proteinuria of glomerular origin. N Engl J Med (1978) 2.61
The distribution and properties of a histamine-methylating enzyme. J Biol Chem (1959) 2.52
Increased sensitivity of the enzymatic isotopic assay of histamine: measurement of histamine in plasma and serum. Anal Biochem (1979) 2.32
Isotopic microassay of histamine, histidine, histidine decarboxylase and histamine methyltransferase in brain tissue. J Neurochem (1972) 1.67
Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules. J Clin Invest (1977) 1.46
Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest (1977) 1.28
Sources of urinary histamine in the rat. Am J Physiol (1954) 1.27
The structural and molecular basis of glomerular filtration. Circ Res (1978) 1.22
Histamine: its role in physiological and pathological processes. Monogr Allergy (1978) 1.17
Histamine (second of two parts). N Engl J Med (1976) 1.09
Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II. J Clin Invest (1978) 1.08
A sensitive and specific enzymatic isotopic assay for tissue histamine. J Pharmacol Exp Ther (1966) 1.08
Experimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics, and polyanion loss. Lab Invest (1977) 1.06
Mechanism of the sustained action of histamine and bradykinin on transport of large molecules across capillary walls in the dog paw. Microvasc Res (1974) 1.06
Histamine and its metabolism in mammals. Part II: Catabolism of histamine and histamine liberation. Agents Actions (1975) 1.04
Renal histamine H1 and H2 receptors: characterization and functional significance. Am J Physiol (1978) 0.99
Effects of histamine and histamine antagonists on intestinal capillary permeability. Am J Physiol (1981) 0.96
Action of serotonin (5-hydroxytryptamine) on cyclic nucleotides in glomeruli of rat renal cortex. Kidney Int (1979) 0.94
Dynamics of the regulation of histamine levels in mouse brain. J Neurochem (1972) 0.93
Renal adaptation to a low phosphate diet in rats. J Clin Invest (1979) 0.92
Metabolic control of permeability in isolated mesentery. Am J Physiol (1974) 0.90
Mechanisms of action of hisamine and histamine antagonists on the glomerular microcirculation in the rat. Circ Res (1979) 0.90
Formation of histamine in the kidney of the dog. Br J Pharmacol Chemother (1958) 0.89
The pathogenesis of minimal change nephropathy. Clin Nephrol (1977) 0.88
Histamine metabolism. I. Thin-layer radiochromatographic assays for histaminase and histidine decarboxylase enzyme activities. J Lab Clin Med (1976) 0.88
Blood and urine histamine levels in normal and pathological states as measured by a radiochemical assay. Clin Chim Acta (1977) 0.88
A new assay for histaminase activity: measurement of tritiated water from beta (side chain label)-H 3-histamine. J Pharmacol Exp Ther (1971) 0.87
Distribution of histamine and histaminase (diamine oxidase)d in blood of various species. Comp Biochem Physiol C (1980) 0.85
Potential role of cyclic nucleotides in glomerular pathophysiology. Adv Cyclic Nucleotide Res (1980) 0.85
Histidine decarboxylase-mediated histamine synthesis in glomeruli from rat kidneys. Am J Physiol (1976) 0.84
Distribution of histidine decarboxylase in the pregnant mouse kidney. Q J Exp Physiol Cogn Med Sci (1971) 0.83
The presence of histamine H2-receptors in rabbit kidney. Arch Int Pharmacodyn Ther (1974) 0.81
Amine formation by rat mast cells in vitro. Acta Physiol Scand (1968) 0.80
Prostaglandins: renal vascular responses to bradykinin, histamine, and nitroglycerine. Am J Physiol (1978) 0.79
Effects of inflammatory mediators on the glomerular localization of intravenously administered ferritins. Experientia (1978) 0.79
Determination of histamine in small biopsies and histological sections. Acta Physiol Scand (1967) 0.79
Mast cell increase in the duodenum and kidney of magnesium-deficient rats. Lab Invest (1975) 0.78
Fluorometric determination of histidine. Clin Chem (1969) 0.78
Effects of dexamethasone on cyclic nucleotide accumulation in glomeruli. J Lab Clin Med (1979) 0.78
The permeability coefficient of albumin of the isolated rat mesentery. Modification by some mediators of inflammation, cyclic AMP and calcium. Biochim Biophys Acta (1979) 0.78
Metabolism of injected [14C] histamine in the kidney of the dog. Br J Pharmacol Chemother (1958) 0.77
Lipogenesis in aminonucleoside-induced nephrotic syndrome. Biochim Biophys Acta (1974) 0.77
Time courses and refractoriness of enhanced vascular permeability induced by histamine, serotonin and bradykinin in synovialis of the rat. Experientia (1979) 0.76
Effect of histamine and antihistamines on renal hemodynamics and functions in the isolated perfused canine kidney. J Pharmacol Exp Ther (1976) 0.76
Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest (1989) 2.41
Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney Int (2008) 2.30
Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology (1997) 2.16
Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol (1988) 2.05
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc Natl Acad Sci U S A (1989) 1.72
Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int (1988) 1.72
Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am J Med (1975) 1.70
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest (1993) 1.54
Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid. J Lab Clin Med (1997) 1.52
In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int (1998) 1.45
Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol (1991) 1.41
Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis (1995) 1.39
The third World Kidney Day: looking back and thinking forward. Clin Nephrol (2008) 1.39
Degradation of human glomerular basement membrane by stimulated neutrophils. Activation of a metalloproteinase(s) by reactive oxygen metabolites. J Clin Invest (1987) 1.38
Nicotinate adenine dinucleotide phosphate (NAADP) triggers a specific calcium release system in sea urchin eggs. J Biol Chem (1995) 1.38
Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int (2001) 1.38
Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev (1999) 1.37
PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma. Oncogene (2008) 1.34
The progression of vesicoureteral reflux nephropathy. Ann Intern Med (1980) 1.31
Nicotinate-adenine dinucleotide phosphate-induced Ca(2+)-release does not behave as a Ca(2+)-induced Ca(2+)-release system. Biochem J (1996) 1.29
Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest (1977) 1.28
Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J Clin Invest (1988) 1.26
An old enzyme with a new function: purification and characterization of a distinct matrix-degrading metalloproteinase in rat kidney cortex and its identification as meprin. J Cell Biol (1994) 1.25
Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am J Physiol (1991) 1.24
Production of platelet-derived growth factorlike protein by rat mesangial cells in culture. J Clin Invest (1987) 1.24
Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest (1991) 1.22
Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes (1997) 1.21
Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis (1997) 1.20
Insulin-like growth factor-I induces renal cell hypertrophy via a calcineurin-dependent mechanism. J Biol Chem (2001) 1.19
Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J (1993) 1.18
Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells. J Clin Invest (1992) 1.17
Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology (1994) 1.17
Phosphonocarboxylic acids as specific inhibitors of Na+-dependent transport of phosphate across renal brush border membrane. J Biol Chem (1986) 1.16
Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care (2000) 1.16
Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease. Am J Kidney Dis (1992) 1.16
Cellular actions of vasopressin in the mammalian kidney. Kidney Int (1976) 1.15
Blood pressure determinants in living-related renal allograft donors and their recipients. Kidney Int (1987) 1.15
Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure. Kidney Int (1996) 1.15
Regulation of mesangial cell growth by polypeptide mitogens. Inhibitory role of transforming growth factor beta. Am J Pathol (1989) 1.14
High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone (2008) 1.14
Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury. Hepatology (1995) 1.14
Phosphatidic acid modulates DNA synthesis, phospholipase C, and platelet-derived growth factor mRNAs in cultured mesangial cells. Role of protein kinase C. J Biol Chem (1990) 1.12
Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol (1999) 1.11
Role of caspases (ICE/CED 3 proteases) in DNA damage and cell death in response to a mitochondrial inhibitor, antimycin A. Kidney Int (1997) 1.11
Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J (2001) 1.10
Apoptotic mechanisms in acute renal failure. Am J Med (2000) 1.10
Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II. J Clin Invest (1978) 1.08
Oxidant mechanisms in gentamicin nephrotoxicity. Ren Fail (1999) 1.08
Effect of histamine and its methyl derivatives on cyclic AMP metabolism in gastric mucosa and its blockade by an H2 receptor antagonist. J Clin Invest (1974) 1.08
Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells. Kidney Int (2001) 1.08
PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF. Am J Physiol (1997) 1.08
Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney Int (2001) 1.07
Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat. J Clin Invest (1981) 1.06
Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Differ (2007) 1.06
Experimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics, and polyanion loss. Lab Invest (1977) 1.06
Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol (1998) 1.06
Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats. J Clin Invest (1985) 1.05
A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. J Exp Med (1994) 1.05
Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria. Am J Physiol (1987) 1.04
Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int (1996) 1.04
Enzymatic synthesis and degradation of nicotinate adenine dinucleotide phosphate (NAADP), a Ca(2+)-releasing agonist, in rat tissues. Biochem Biophys Res Commun (1995) 1.04
Glucagon-sensitive adenylate cyclase in human renal medulla. J Clin Endocrinol Metab (1976) 1.04
Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. Am J Physiol (1992) 1.04
Enhanced in vivo H2O2 generation by rat kidney in glycerol-induced renal failure. Am J Physiol (1989) 1.03
Ca2+ release triggered by nicotinate adenine dinucleotide phosphate in intact sea urchin eggs. Biochem J (1995) 1.03
The risks of unilateral nephrectomy: status of kidney donors 10 to 20 years postoperatively. Mayo Clin Proc (1985) 1.03
Preferences regarding genetic research results: comparing veterans and nonveterans responses. Public Health Genomics (2010) 1.03
Transport of citrate across renal brush border membrane: effects of dietary acid and alkali loading. Am J Physiol (1985) 1.02
Effects of PDGF on inositol phosphates, Ca2+, and contraction of mesangial cells. Am J Physiol (1987) 1.02
Effects of demethylchlortetracycline on cellular action of antidiuretic hormone in vitro. Kidney Int (1974) 1.02
Role of reactive oxygen metabolites in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells. Am J Physiol (1996) 1.02
Meprin A, the major matrix degrading enzyme in renal tubules, produces a novel nidogen fragment in vitro and in vivo. Kidney Int (1998) 1.01
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant (1995) 1.01
Acute intrinsic renal failure induced by indomethacin: role of prostaglandin synthetase inhibition. Mayo Clin Proc (1982) 1.01
Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int (1981) 1.01
Effect of renal medullary solutes on vasopressin-sensitive adenyl cyclase. Am J Physiol (1972) 1.00
Ablation of the gene encoding p66Shc protects mice against AGE-induced glomerulopathy by preventing oxidant-dependent tissue injury and further AGE accumulation. Diabetologia (2007) 1.00
Chemokines and renal disease. Am J Kidney Dis (1995) 1.00
Role of cyclic AMP in the action of neurohypophyseal hormones on kidney. Adv Cyclic Nucleotide Res (1972) 1.00
Proteolytic enzymes as mediators of glomerular injury. Kidney Int (1991) 0.99
Role of meprin A in renal tubular epithelial cell injury. Kidney Int (2007) 0.99
In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli. Am J Physiol (1989) 0.98
Diazontized (125I) diiodosulafanilic acid as a label for cell surface membranes. Studies on erythrocytes. Biochim Biophys Acta (1979) 0.98
Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation. Mayo Clin Proc (1984) 0.98
Inhibition of human renal epithelial Na+/Pi cotransport by phosphonoformic acid. Biochem Biophys Res Commun (1986) 0.98
Influence of parathyroid hormone on glomerular ultrafiltration in the rat. Am J Physiol (1978) 0.98
Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors. J Clin Invest (1985) 0.98
Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis (1987) 0.97
Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus. Am J Physiol (1991) 0.97
Parathyroid hormone receptors of renal cortex: specific binding of biologically active, 125I-labeled hormone and relationship to adenylate cyclase activation. Proc Natl Acad Sci U S A (1974) 0.97
ANP inhibits Na(+)-H+ antiport in proximal tubular brush border membrane: role of dopamine. Kidney Int (1990) 0.97
Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity. Kidney Int (1998) 0.97
Donor scoring system for cadaveric renal transplantation. Am J Transplant (2001) 0.96
Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int (1997) 0.96
Mechanism of glucocorticoid effect on renal transport of phosphate. Am J Physiol (1982) 0.96
ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation. Circ Res (2000) 0.96
Activation of a 15-kDa endonuclease in hypoxia/reoxygenation injury without morphologic features of apoptosis. Proc Natl Acad Sci U S A (1995) 0.96
Cyclic AMP in action of antidiuretic hormone: effects of exogenous cyclic AMP and its new analogue. Am J Physiol (1977) 0.96